A novel glycoengineering platform, created by the laboratory of Assistant Professor Chris Lok-To Sham from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), is poised to revolutionize future production of vaccines and therapeutics to fight infectious diseases. Glycoengineering aims to manipulate sugars to produce useful carbohydrates. This innovative platform simplifies the customizing and production of sugar carbohydrates known as glycans that plays a crucial role in various therapeutic applications.
